| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07377526 Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In… |
Recruitment opened |
| 2026-06-11 | NCT06235801 A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-10 | NCT06909201 Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving… |
Phase changed: ['PHASE1'] -> [] |
| 2026-06-09 | NCT06113302 A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-09 | NCT06113302 A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic… |
Enrollment reduced: 40 -> 10 participants |
| 2026-06-06 | NCT04550442 Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk… |
Trial terminated |
| 2026-06-06 | NCT04550442 Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk… |
critical why stopped: null → "\\<75% participation" |
| 2026-06-06 | NCT04550442 Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk… |
date change Primary completion pushed: 2026-03-31 -> 2026-05-29 |
| 2026-06-06 | NCT04550442 Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk… |
date change Completion pushed: 2026-03-31 -> 2026-05-29 |
| 2026-06-06 | NCT04188405 Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia… |
Trial completed |
| 2026-06-06 | NCT04188405 Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia… |
date change Primary completion moved earlier: 2026-11-30 -> 2026-06-02 |
| 2026-06-06 | NCT04188405 Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia… |
date change Completion moved earlier: 2026-11-30 -> 2026-06-02 |
| 2026-06-03 | NCT07508982 Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML |
Recruitment opened |
| 2026-06-03 | NCT06015295 A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-03 | NCT06015295 A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for… |
Enrollment reduced: 20 -> 3 participants |
| 2026-06-03 | NCT04128748 Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-03 | NCT05681039 Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-03 | NCT02379377 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT05039801 IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid… |
date change Primary completion pushed: 2026-05-29 -> 2028-03-30 |
| 2026-06-02 | NCT05039801 IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid… |
date change Completion pushed: 2026-05-29 -> 2028-06-30 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-08 | NCT07633756 A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With… | Phase 1 | Not Yet Recruiting |
| 2026-06-05 | NCT07631013 Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant… | Phase 1 | Not Yet Recruiting |
| 2026-06-05 | NCT07631026 Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery | Not Yet Recruiting | |
| 2026-05-28 | NCT07610499 Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During… | Not Yet Recruiting | |
| 2026-05-28 | NCT07610525 Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage… | Phase 2 | Not Yet Recruiting |
| 2026-05-22 | NCT07604233 Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML | Phase 1/2 | Not Yet Recruiting |
| 2026-05-18 | NCT07591623 OCRA Distress & Unmet Needs | Not Yet Recruiting | |
| 2026-05-18 | NCT07591701 Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B… | Not Yet Recruiting | |
| 2026-05-15 | NCT07591480 Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04604509 | Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking… | Cigarette Smoking-Related Carcinoma | Recruiting |
| NCT04265430 | Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in… | Malignant Oral Cavity Neoplasm | Recruiting |
| NCT06162377 | Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of… | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT04296305 | Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone… | Hematopoietic and Lymphoid Cell Neoplasm | Active, Not Recruiting |
| NCT02162849 | Reward Sensitivity and Pharmacotherapy for Smoking Cessation | Tobacco Use Cessation | Active, Not Recruiting |
| NCT06049134 | Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20)… | Lymphoma | Active, Not Recruiting |
| NCT03023631 | Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies… | Allogeneic Hematopoietic Stem Cell Transplant Recipient | Active, Not Recruiting |
| Phase 3 | |||
| NCT05774678 | Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated… | Breast Cancer | Recruiting |
| NCT05053867 | A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary… | Pulmonary Hemorrhage | Recruiting |
| NCT06065449 | A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs… | Bone Metastases | Recruiting |
| NCT04575935 | Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage… | Advanced Ovarian Carcinoma | Recruiting |
| NCT03583710 | Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With… | ENSAT Stage I Adrenal Cortex Carcinoma | Recruiting |
| NCT01696734 | Domperidone in Treating Patients With Gastrointestinal Disorders | Digestive System Disorder | Recruiting |
| NCT06851507 | A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene… | Multiple Actinic Keratoses | Recruiting |
| NCT06274047 | PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and… | Androgen Axis Suppression | Recruiting |
| NCT06593431 | Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease… | Pancreas Cancer | Recruiting |
| NCT06200181 | Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for… | Misuse, Opioid | Recruiting |
| NCT07318363 | IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment)… | Communication | Not Yet Recruiting |
| NCT04188418 | Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients | Hematopoietic and Lymphoid Cell Neoplasm | Active, Not Recruiting |
| NCT00950001 | Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain… | Metastatic Malignant Neoplasm in the Brain | Active, Not Recruiting |
| NCT01893307 | Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating… | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Active, Not Recruiting |
| NCT05836870 | Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation… | Pancreatic Cancer | Active, Not Recruiting |
| NCT03214510 | Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in… | Liver and Intrahepatic Bile Duct Disorder | Active, Not Recruiting |
| NCT01592968 | Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With… | Metastatic Malignant Neoplasm | Active, Not Recruiting |
| NCT04810091 | Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With… | Locally Advanced Neuroendocrine Neoplasm | Active, Not Recruiting |